Oncology Central

Kymriah® is set to become the first CAR-T therapy available on the NHS

The ground breaking CAR-T therapy – Kymriah® – (tisagenlecleucel) is set to become the first personalized cancer therapy available on the NHS.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.